Published in Front Pharmacol on February 02, 2015
Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res (2016) 0.80
Kidney tubules: intertubular, vascular, and glomerular cross-talk. Curr Opin Nephrol Hypertens (2016) 0.78
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79
Chronic kidney disease. Lancet (2011) 5.42
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int (2009) 4.02
Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int (2006) 2.12
Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int (2001) 2.10
Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest (2014) 2.07
Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97
Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens (2004) 1.92
A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol (2002) 1.88
Toward a unified theory of renal progression. Annu Rev Med (2006) 1.81
Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney Int (2009) 1.78
The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J (2006) 1.72
The global challenge of chronic kidney disease. Kidney Int (2005) 1.62
LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol (2007) 1.51
Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Hypertens Res (2010) 1.47
Reliability of real-time reverse-transcription PCR in clinical diagnostics: gold standard or substandard? Expert Rev Mol Diagn (2009) 1.44
Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int (1995) 1.42
An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int (2010) 1.39
Snail1 is involved in the renal epithelial-mesenchymal transition. Biochem Biophys Res Commun (2007) 1.29
Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol (2004) 1.20
Obstructive nephropathy. Intern Med (2000) 1.06
Emerging therapies for chronic kidney disease: what is their role? Nat Rev Nephrol (2009) 1.03
Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol (1996) 1.01
In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest (2002) 1.01
Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J (2008) 0.98
Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. Am J Nephrol (2007) 0.92
Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am Soc Nephrol (2010) 0.91
Heat shock protein 47 and renal fibrogenesis. Contrib Nephrol (2005) 0.91
Potential methods to prevent interstitial fibrosis in renal disease. Expert Opin Investig Drugs (2001) 0.85
Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor. Biochem Biophys Res Commun (2009) 0.85
Des-Arg(10)-kallidin engagement of the B1 receptor stimulates type I collagen synthesis via stabilization of connective tissue growth factor mRNA. J Biol Chem (2000) 0.84
Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice. Nephrology (Carlton) (2010) 0.83